Continuous Live Cell Analysis at Sygnature Discovery

Video   Feb 08, 2017

 
 
 

In July 2015, Sygnature and Essen BioScience Ltd., a world leader in the field of cell-based in vitro assays and instrumentation, announced that they had established a strategic alliance to incorporate Essen’s unique phenotypic assay, live-cell imaging and ion channel technologies into Sygnature’s integrated drug discovery projects. This alliance has been very productive and has also resulted in the addition of the IncuCyte® ZOOM System by Sygnature into its in-house capabilities. IncuCyte® ZOOM offers plate-based continuous cell imaging within a controlled tissue-culture environment, allowing real time quantitative live-cell, non-invasive analysis. Assaying cellular systems using live-cell imaging affords an array of advantages when compared to classical single end-point functional cellular assay read-outs; these include, label-free analysis, no cell disruption during analysis, multiplexing and kinetic data generation. The adoption of the IncuCyte® ZOOM System has enhanced Sygnature’s research expertise across a broad range of therapeutic areas including oncology, immunology, inflammation and neuroscience.

 
Company Information
 
 
 

Recommended Videos

What is Dementia?

Video

Which diseases cause dementia? How do they affect the brain? What symptoms do they lead to? Voiced by Game of Thrones star Iwan Rheon, this short introduction explains the essentials of a condition affecting 850,000 people across the UK today.

WATCH NOW

Your Brain on Coffee

Video

This video from ASAP Science illustrates how the World's favorite drug affects your brain.

WATCH NOW

CRISPR Explained

Video

Biologist Neville Sanjana talks CRISPR to a 7 year-old, a 14 year-old, a college student, a grad student and a CRISPR expert.

WATCH NOW

 

Comments | 0 ADD COMMENT

Like what you just watched? You can find similar content on the communities below.

Analysis & Separations Cell Science Drug Discovery Neuroscience

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE